Filing Details

Accession Number:
0001104659-15-000899
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-01-07 09:48:36
Reporting Period:
2014-12-23
Filing Date:
2015-01-07
Accepted Time:
2015-01-07 09:48:36
Original Submission Date:
2014-12-24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1526119 Verastem Inc. VSTM Pharmaceutical Preparations (2834) 273269467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021038 A Henri Termeer C/O Verastem, Inc.,
117 Kendrick Street, Suite 500
Needham MA 02494
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-12-23 15,000 $8.11 32,179 No 4 P Direct
Common Stock Acquisiton 2014-12-23 14,000 $8.11 14,000 No 4 P Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By wife
Footnotes
  1. 6,000 of these shares were omitted from the reporting person's original Form 4.
  2. 3,900 of these shares were omitted from the reporting person's original Form 4.
  3. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $8.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4.
  4. The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.02 to $8.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4.